Answers are grounded in this paper and cite their sources.
. These additional mutations often influence prognosis in MPNs and therefore are increasingly important for risk stratification. This review focuses on the molecular alterations within the WHO classification of MPNs and laboratory testing used for diagnosis.
No takes yet. Share an insight, caveat, or question.
Easwar et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: